Chemical activators of C5orf43 can play a significant role in its functional state through various cellular mechanisms. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can directly phosphorylate C5orf43, thus leading to its activation. Similarly, Forskolin acts on adenylyl cyclase to increase cAMP levels, which in turn activate protein kinase A (PKA). PKA is another kinase that can phosphorylate C5orf43, triggering its activation. Ionomycin, by increasing intracellular calcium, activates calcium/calmodulin-dependent protein kinases (CaMKs), which may also phosphorylate and consequently activate C5orf43. The disruption of calcium homeostasis by Thapsigargin can also activate CaMKs, suggesting another route to the activation of C5orf43. Additionally, the inhibition of protein phosphatases by Okadaic Acid and Calyculin A results in an overall increase in the phosphorylation of proteins, which can lead to the activation of C5orf43.
Other molecules such as Epigallocatechin gallate (EGCG) inhibit certain kinases, which could create a compensatory activation of signaling pathways leading to the phosphorylation of C5orf43. (-)-Blebbistatin alters myosin II activity and through changes in cytoskeletal dynamics, it can influence pathways that activate C5orf43. The cell-permeable cAMP analog, Dibutyryl cyclic AMP (db-cAMP), ensures the activation of PKA, which, similar to Forskolin, can lead to the phosphorylation and activation of C5orf43. Chelerythrine, while generally known as a PKC inhibitor, can paradoxically activate certain PKC isoforms that could phosphorylate C5orf43. A23187 (Calcimycin) and Anisomycin activate calcium-dependent enzymes and stress-activated protein kinases, respectively, both of which can result in the activation of C5orf43 through phosphorylation. These chemical activators demonstrate the diverse cellular signaling pathways that can converge on the phosphorylation and subsequent activation of C5orf43.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) which is involved in the phosphorylation of many proteins. PKC, upon activation, can phosphorylate C5orf43, leading to its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin increases intracellular calcium concentration, which can activate calcium/calmodulin-dependent protein kinases (CaMKs). These kinases can phosphorylate C5orf43, leading to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic acid inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation levels of cellular proteins. This inhibition can lead to the phosphorylation and activation of C5orf43. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Calyculin A, like okadaic acid, inhibits protein phosphatases, particularly PP1 and PP2A, leading to the activation of C5orf43 through increased phosphorylation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG can inhibit certain types of kinases, potentially altering the balance of kinase activity in the cell, which can lead to compensatory phosphorylation and activation of C5orf43. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $71.00 $260.00 $485.00 $949.00 | ||
(-)-Blebbistatin affects myosin II activity, altering cytoskeletal dynamics, which can influence signaling pathways that lead to the phosphorylation and activation of C5orf43. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin disrupts calcium storage in the endoplasmic reticulum, increasing cytosolic calcium levels. This can lead to the activation of calcium-dependent enzymes that may phosphorylate and activate C5orf43. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
db-cAMP serves as a cell-permeable analog of cyclic AMP, which activates PKA. Activated PKA is capable of phosphorylating C5orf43, leading to its activation. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is known as a PKC inhibitor, but it can also lead to selective activation of certain PKC isoforms, which can phosphorylate and activate C5orf43. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 acts as an ionophore that increases intracellular calcium, activating CaMKs, and potentially leading to the phosphorylation and activation of C5orf43. |